COVID-19: Consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients - Chakraborty, C; Sharma, A R; Bhattacharya, M; Sharma, G; Lee, S S; Agoramoorthy, G (J Med Virol, 2020)